blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1617875

EP1617875 - NOVEL USE OF AIM3 ACTING AS A TUMOR SUPPRESSOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.06.2018
Database last updated on 04.11.2024
FormerThe patent has been granted
Status updated on  14.07.2017
FormerGrant of patent is intended
Status updated on  02.03.2017
Most recent event   Tooltip29.05.2020Lapse of the patent in a contracting state
New state(s): PT		published on 01.07.2020  [2020/27]
Applicant(s)For all designated states
Medical Bioconvergence Research Center
8th Fl. B-dong
Advanced Institutes of Convergence Technology
864-1, lui-dong, Yeongtong-gu
Suwon-si, Gyeonggi-do 443-270 / KR
[2014/15]
Former [2014/13]For all designated states
Medicinal Bioconvergence Research Center
8th Fl. B-dong
Advanced Institutes of Convergence Technology
864-1, lui-dong, Yeongtong-gu
Suwon-si, Gyeonggi-do 443-270 / KR
Former [2006/04]For all designated states
Seoul National University Industry Foundation
San 4-2, Bongcheon-dong Gwanak-gu
Seoul 151-742 / KR
Inventor(s)01 / KIM, Sunghoon, @Tower Palace
F-1709 Dogok 2-dong, Gangnam-gu
Seoul 135-536 / KR
 [2017/33]
Former [2006/04]01 / KIM, Sunghoon, Tower Palace
F-1709 Dogok 2-dong, Gangnam-gu
Seoul 135-536 / KR
Representative(s)Bockhorni & Brüntjen Partnerschaft Patentanwälte mbB
Agnes-Bernauer-Straße 88
80687 München / DE
[N/P]
Former [2017/33]Bockhorni & Kollegen
Elsenheimerstraße 49
80687 München / DE
Former [2008/31]Bockhorni & Kollegen
Elsenheimerstrasse 49
80687 München / DE
Former [2006/04]GROSSE BOCKHORNI SCHUMACHER
Patent- und Rechtsanwälte Forstenrieder Allee 59
81476 München / DE
Application number, filing date04774463.601.09.2004
[2006/04]
WO2004KR02202
Priority number, dateKR2004002920527.04.2004         Original published format: KR 2004029205
[2006/04]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005102395
Date:03.11.2005
Language:EN
[2005/44]
Type: A1 Application with search report 
No.:EP1617875
Date:25.01.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 03.11.2005 takes the place of the publication of the European patent application.
[2006/04]
Type: B1 Patent specification 
No.:EP1617875
Date:16.08.2017
Language:EN
[2017/33]
Search report(s)International search report - published on:KR03.11.2005
(Supplementary) European search report - dispatched on:EP11.09.2007
ClassificationIPC:A61K48/00, A61K38/00
[2006/04]
CPC:
A61K38/1709 (EP,US); A61K48/00 (EP,KR,US); A61K38/53 (EP,US);
A61P13/08 (EP); A61P13/10 (EP); A61P17/06 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P43/00 (EP);
C07K14/47 (EP,US); C07K14/4702 (EP,US); C12N9/93 (EP,US);
G01N33/574 (EP,US); G01N33/6893 (EP,US); A01K2217/054 (EP,US);
G01N2333/4703 (EP,US); G01N2500/04 (EP,US); G01N2800/205 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/33]
Former [2006/04]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:NEUARTIGE VERWENDUNG VON AIM3 ALS TUMORSUPPRESSOR[2006/04]
English:NOVEL USE OF AIM3 ACTING AS A TUMOR SUPPRESSOR[2006/04]
French:NOUVELLE UTILISATION DE LA PROTEINE 3 MULTIFONCTIONNELLE INTERAGISSANT AVEC L'AMINOACYL-TARN SYNTHASE (AIM3) COMME SUPPRESSEUR TUMORAL[2006/04]
Entry into regional phase25.05.2005Translation filed 
25.05.2005National basic fee paid 
25.05.2005Search fee paid 
25.05.2005Designation fee(s) paid 
25.05.2005Examination fee paid 
Examination procedure25.05.2005Examination requested  [2006/04]
20.03.2009Despatch of a communication from the examining division (Time limit: M06)
18.09.2009Reply to a communication from the examining division
29.07.2010Despatch of a communication from the examining division (Time limit: M04)
26.11.2010Reply to a communication from the examining division
24.06.2013Despatch of a communication from the examining division (Time limit: M04)
13.09.2013Reply to a communication from the examining division
05.05.2015Despatch of a communication from the examining division (Time limit: M02)
03.07.2015Reply to a communication from the examining division
04.03.2016Despatch of a communication from the examining division (Time limit: M04)
24.06.2016Reply to a communication from the examining division
03.03.2017Communication of intention to grant the patent
29.06.2017Fee for grant paid
29.06.2017Fee for publishing/printing paid
29.06.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.03.2009
Opposition(s)17.05.2018No opposition filed within time limit [2018/30]
Fees paidRenewal fee
28.09.2006Renewal fee patent year 03
27.09.2007Renewal fee patent year 04
17.09.2008Renewal fee patent year 05
21.09.2009Renewal fee patent year 06
15.09.2010Renewal fee patent year 07
16.09.2011Renewal fee patent year 08
26.09.2012Renewal fee patent year 09
12.09.2013Renewal fee patent year 10
16.09.2014Renewal fee patent year 11
22.09.2015Renewal fee patent year 12
27.09.2016Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.09.2004
AT16.08.2017
CY16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
PT16.08.2017
RO16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
TR16.08.2017
IE01.09.2017
LU01.09.2017
BE30.09.2017
CH30.09.2017
LI30.09.2017
FR16.10.2017
BG16.11.2017
GB16.11.2017
GR17.11.2017
DE04.04.2018
[2020/27]
Former [2020/16]HU01.09.2004
AT16.08.2017
CY16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
TR16.08.2017
IE01.09.2017
LU01.09.2017
BE30.09.2017
CH30.09.2017
LI30.09.2017
FR16.10.2017
BG16.11.2017
GB16.11.2017
GR17.11.2017
DE04.04.2018
Former [2019/46]HU01.09.2004
AT16.08.2017
CY16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
IE01.09.2017
LU01.09.2017
BE30.09.2017
CH30.09.2017
LI30.09.2017
FR16.10.2017
BG16.11.2017
GB16.11.2017
GR17.11.2017
DE04.04.2018
Former [2019/31]HU01.09.2004
AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
IE01.09.2017
LU01.09.2017
BE30.09.2017
CH30.09.2017
LI30.09.2017
FR16.10.2017
BG16.11.2017
GB16.11.2017
GR17.11.2017
DE04.04.2018
Former [2018/50]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
IE01.09.2017
LU01.09.2017
BE30.09.2017
CH30.09.2017
LI30.09.2017
FR16.10.2017
BG16.11.2017
GB16.11.2017
GR17.11.2017
DE04.04.2018
Former [2018/39]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
IE01.09.2017
LU01.09.2017
BE30.09.2017
CH30.09.2017
LI30.09.2017
FR16.10.2017
BG16.11.2017
GR17.11.2017
DE04.04.2018
Former [2018/36]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SK16.08.2017
IE01.09.2017
LU01.09.2017
BE30.09.2017
CH30.09.2017
LI30.09.2017
BG16.11.2017
GR17.11.2017
DE04.04.2018
Former [2018/34]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SK16.08.2017
IE01.09.2017
LU01.09.2017
CH30.09.2017
LI30.09.2017
BG16.11.2017
GR17.11.2017
DE04.04.2018
Former [2018/30]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SK16.08.2017
LU01.09.2017
BG16.11.2017
GR17.11.2017
Former [2018/26]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SK16.08.2017
BG16.11.2017
GR17.11.2017
Former [2018/24]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SK16.08.2017
BG16.11.2017
GR17.11.2017
Former [2018/23]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
SE16.08.2017
SK16.08.2017
BG16.11.2017
GR17.11.2017
Former [2018/21]AT16.08.2017
CZ16.08.2017
DK16.08.2017
ES16.08.2017
FI16.08.2017
NL16.08.2017
PL16.08.2017
SE16.08.2017
BG16.11.2017
GR17.11.2017
Former [2018/12]AT16.08.2017
ES16.08.2017
FI16.08.2017
NL16.08.2017
PL16.08.2017
SE16.08.2017
BG16.11.2017
GR17.11.2017
Former [2018/10]AT16.08.2017
FI16.08.2017
NL16.08.2017
SE16.08.2017
Former [2018/09]FI16.08.2017
NL16.08.2017
SE16.08.2017
Former [2018/08]FI16.08.2017
NL16.08.2017
Documents cited:Search[X]WO9946292  (UNIV SHANGHAI 2ND MEDICAL [CN], et al) [X] 7-24 * the whole document *;
 [X]US2004010134  (ROSEN CRAIG A [US], et al) [X] 7-24 * page 87; claims 20-25; table 1 *;
 [X]  - CENTER FOR MEDICINAL PROTEIN NETWORK AND SYSTEMS BIOLOGY, "MEDIWEB>RESEARCH>CONTRIBUTED PAPERS", (2003), URL: http://mediweb.snu.ac.kr/Research/Seminar.php?Category=ContributedPapers, (20070823), XP002447756 [X] 1-4,9-18,22 * Reference No. 17 *
 [PX]  - PARK BUM-JOON ET AL, "The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR", CELL, (20050128), vol. 120, no. 2, ISSN 0092-8674, pages 209 - 221, XP002447757 [PX] 1-24 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.cell.2004.11.054
International search[X]  - MAO ET AL, "Identification of genes expressed in human CD34(+) hematopoietic stem/progenitorcells by expressed sequence tags and efficient full-length cDNA cloning.", GENBANK, Database accession no. (AF054186), XP002997330
    [ ] - PROC NATL ACAD SCI USA., (19980707), vol. 95, no. 14, pages 8175 - 8180, XP002997332

DOI:   http://dx.doi.org/10.1073/pnas.95.14.8175
 [A]  - QUEVILLON ET AL, "The p18 component of the multisynthetase complex shares a protein motif with thebeta and gamma subunits of eukaryotic elongation factor 1.", FEBS LETTERS., (19961014), vol. 395, no. 1, pages 63 - 67, XP002997331

DOI:   http://dx.doi.org/10.1016/0014-5793(96)01005-8
 [A]  - KO ET AL, "Novel regulatory interactions and activities of mammalian tRNA synthetases.", PROTEOMICS., (200209), vol. 2, no. 9, pages 1304 - 1310, XP002997344

DOI:   http://dx.doi.org/10.1002/1615-9861(200209)2:9<1304::AID-PROT1304>3.0.CO;2-E
 [A]  - RHO ET AL, "Genetic dissection of protein-protein interactions in multi-tRNA synthetase complex.", PROC NATL ACAD SCI USA., (19990413), vol. 96, no. 8, pages 4488 - 4493, XP002997333

DOI:   http://dx.doi.org/10.1073/pnas.96.8.4488
by applicant   - KO ET AL., J BIOL. CHEM., (2001), vol. 276, pages 23028 - 32303
    - PARK ET AL., J BIOL. CHEM., (2002), vol. 277, pages 45234 - 45248
    - KIM ET AL., NAT. GENET., (2003), vol. 34, pages 330 - 336
    - QUEVILLON; MIRANDE, FEBS LETT., (1996), vol. 395, pages 63 - 67
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.